Procter & Gamble CO Form 4 insider transactions

Balaji Purushothaman, Chief Human Resources Officer at Procter & Gamble, reports the acquisition of 2,031 shares of common stock through a stock award.

CEO Jon Moeller reports a stock award and forfeiture of unvested stock options due to his spouse's retirement.

Jon Moeller, Chairman, President, and CEO of Procter & Gamble, exercised stock options and sold shares of common stock on August 9, 2024.

Keith R. Alexandra, CEO Beauty at Procter & Gamble, reported the sale of 4,163 shares of common stock on August 8, 2024.

Gary A. Coombe, CEO Grooming at Procter & Gamble, exercised stock options and sold shares of common stock on August 8, 2024.

Keith R. Alexandra, CEO Beauty at Procter & Gamble, reported selling 3,373 shares of common stock on August 5, 2024, to cover tax obligations.

Chief Operating Officer Shailesh Jejurikar reports transactions involving Procter & Gamble common stock and restricted stock units.

Chief Legal Officer & Secretary Susan Whaley reports transactions involving Procter & Gamble stock, including acquisitions of restricted stock units and adjustments to retirement plan holdings.

Sundar G. Raman, a Procter & Gamble executive, filed a Form 4 detailing changes in his beneficial ownership of the company's securities, including common stock, preferred stock, and restricted stock units.

Andre Schulten, CFO of Procter & Gamble, filed a Form 4 detailing changes in his beneficial ownership of company stock, including acquisitions of restricted stock units and adjustments to holdings in retirement plans.

Jennifer L. Davis, CEO Health Care at Procter & Gamble, filed a Form 4 detailing changes in her beneficial ownership of company stock and derivative securities.

Chief Brand Officer Marc S. Pritchard reports changes in beneficial ownership of Procter & Gamble stock, including acquisitions of restricted stock units and adjustments to holdings in retirement plans.

Ma. Fatima Francisco, a Procter & Gamble executive, filed a Form 4 detailing changes in beneficial ownership of company stock, including acquisitions of restricted stock units and adjustments to holdings through retirement plans.

Matthew W. Janzaruk, SVP Chief Accounting Officer of Procter & Gamble, reports acquisition of common stock and Series A Preferred Stock through restricted stock units and retirement plan transactions.

Procter & Gamble's CEO, Jon Moeller, filed a Form 4 detailing changes in his beneficial ownership of company stock, including acquisitions of restricted stock units and adjustments to holdings in retirement plans.

Alexandra Keith, a CEO at Procter & Gamble, reported changes in beneficial ownership of company stock, including acquisitions of common stock and restricted stock units.

Balaji Purushothaman, Chief Human Resources Officer at Procter & Gamble, reports the acquisition and disposal of company stock and derivative securities.

Gary A. Coombe, CEO Grooming at Procter & Gamble, reports transactions involving common stock and restricted stock units.

Chief Research, Development & Innovation Officer of Procter & Gamble, Moses Victor Javier Aguilar, reports transactions involving common stock and restricted stock units.

Director Angela F. Braly reports acquisition of 165 shares of Procter & Gamble Co. stock through restricted stock units and dividend reinvestment.

Director Patricia Woertz acquired 180 shares of Procter & Gamble common stock through the company's stock and incentive compensation plan on June 11, 2024.

Director Robert Portman acquired 45 shares of Procter & Gamble common stock on June 11, 2024, through the company's stock and incentive compensation plan.

Director Ashley McEvoy reports the acquisition of 180 shares of Procter & Gamble common stock on June 11, 2024, as part of the company's 2019 Stock and Incentive Compensation Plan.

Director Christine M. McCarthy reported the acquisition of 224 restricted stock units of Procter & Gamble on June 11, 2024.

Director Terry J. Lundgren reports acquiring 217 shares of Procter & Gamble common stock through restricted stock units and dividend reinvestment.

Director Joseph Jimenez reports acquiring 284 shares of Procter & Gamble common stock through restricted stock units.

Director Christopher Kempczinski reports the acquisition of 180 Restricted Stock Units in Procter & Gamble, with a post-transaction holding of 6,727.2796 shares.

Director M. Brett Biggs reports acquisition of Procter & Gamble restricted stock units.

Director B. Marc Allen reports acquiring 180 shares of Procter & Gamble common stock through restricted stock units and dividend equivalents.

Sundar G. Raman, a Procter & Gamble executive, reported the acquisition and disposal of company stock and derivative securities.